RAPP

21.33

1.81% 0.38

Handel nachbörslich: 21.33

Rapport Therapeutics Inc (RAPP)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$20.95

Offen:

$21.27

24-Stunden-Volumen:

122.03K

Relative Volume:

0.89

Marktkapitalisierung:

$780.18M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-20.71%

1M Leistung:

-17.80%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$20.90

$22.18

1-Wochen-Bereich:

$20.20

$27.26

52-Wochen-Spanne:

$16.55

$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Firmenname

Rapport Therapeutics Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

857-321-8020

Adresse

1325 BOYLSTON STREET, BOSTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

RAPP's Discussions on Twitter

Vergleichen Sie RAPP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RAPP	21.33	780.18M	0	0	0	0.00
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten

09:08 AM

(RAPP) Investment Analysis and Advice - Stock Traders Daily

09:08 AM

Nov 17, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 6.5% – Should You Sell? - Defense World

Nov 17, 2024

Nov 15, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%Time to Sell? - MarketBeat

Nov 15, 2024

Nov 14, 2024

Cormorant Asset Management's Strategic Acquisition in Rapport Th - GuruFocus.com

Nov 14, 2024

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting - GlobeNewswire

Nov 14, 2024

Rapport Therapeutics to Present Phase 2a Epilepsy Drug Data at Major Conference | RAPP Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

FMR LLC's Strategic Acquisition in Rapport Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 11, 2024

Cartesian Therapeutics (NASDAQ:RNAC) & Rapport Therapeutics (NASDAQ:RAPP) Head to Head Comparison - Defense World

Nov 11, 2024

Nov 09, 2024

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update - The Manila Times

Nov 07, 2024

Rapport (RAPP) Hit With FDA Hold Despite $320M Cash Position; Q3 Loss Widens | RAPP Stock News - StockTitan

Nov 07, 2024

Nov 04, 2024

Rapport Therapeutics to Present at Stifel Healthcare - GlobeNewswire

Nov 04, 2024

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November - StockTitan

Nov 04, 2024

Nov 03, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up – Still a Buy? - Defense World

Nov 03, 2024

Nov 01, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Nov 01, 2024

Oct 28, 2024

SG Americas Securities LLC Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Oct 28, 2024

(RAPP) Trading Report - Stock Traders Daily

Oct 28, 2024

Oct 25, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 4.2%Here's Why - MarketBeat

Oct 25, 2024

Oct 21, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap DownShould You Sell? - MarketBeat

Oct 21, 2024

Oct 19, 2024

Jones Trading Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - MSN

Oct 19, 2024

Oct 18, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.7%Time to Sell? - MarketBeat

Oct 18, 2024

This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - MSN

Oct 18, 2024

Oct 17, 2024

When (RAPP) Moves Investors should Listen - Stock Traders Daily

Oct 17, 2024

Oct 16, 2024

Rapport Therapeutics (NASDAQ:RAPP) Sets New 1-Year HighTime to Buy? - MarketBeat

Oct 16, 2024

Millennium Management LLC Makes New $2.72 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Oct 16, 2024

Oct 15, 2024

Rapport Therapeutics (NASDAQ:RAPP) Short Interest Up 32.4% in September - MarketBeat

Oct 15, 2024

Oct 14, 2024

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.3%What's Next? - MarketBeat

Oct 14, 2024

Oct 11, 2024

75,516 Shares in Rapport Therapeutics (NASDAQ:RAPP) Purchased by The Manufacturers Life Insurance Company - MarketBeat

Oct 11, 2024

Oct 10, 2024

Two more Mass. biotechs raise $330M in IPOs, to debut on Nasdaq - The Business Journals

Oct 10, 2024

Oct 06, 2024

(RAPP) On The My Stocks Page - Stock Traders Daily

Oct 06, 2024

Oct 04, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Up 7%Should You Buy? - MarketBeat

Oct 04, 2024

Oct 02, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 4.1% - MarketBeat

Oct 02, 2024

Oct 01, 2024

Logos Global Management LP Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Oct 01, 2024

Sep 30, 2024

Perceptive Advisors LLC Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 30, 2024

Sep 28, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading 6.2% Higher - MarketBeat

Sep 28, 2024

Sep 27, 2024

GC Therapeutics: $65 Million (Series A) Raised To Unlock The Next Generation Of Cell Therapy-Based Medicines - Pulse 2.0

Sep 27, 2024

Sep 25, 2024

(RAPP) Technical Data - Stock Traders Daily

Sep 25, 2024

Sep 24, 2024

ARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Sep 24, 2024

ARCH Venture Management LLC Invests $86.73 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 24, 2024

GC Therapeutics Raises $65M Series A - citybiz

Sep 24, 2024

Sep 23, 2024

Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals

Sep 23, 2024